BAC vs CHRD Stock Comparison
CHRD currently leads BAC in this stock comparison, with AIQ scores of 61 vs 47. The clearest difference is momentum, while BAC has the stronger risk resilience profile.
What is the main difference between BAC and CHRD?
CHRD leads the current stock comparison as Chord Energy Corporation, with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Bank of America Corporation vs Chord Energy Corporation
CHRD leads
CHRD leads by 14 AIQ points, primarily on Momentum and Value, and the lead has widened from 8 points over 30 sessions. Wall Street currently favors BAC on target upside.
Stable: 3 of 6 evidence groups support CHRD, its lead is widening, and its signal state is cleanly positive.
Bank of America Corporation
Chord Energy Corporation
The Algovestiq AIQ Score currently favors CHRD over BAC, 61 versus 47 as of Oct 31, 2026. CHRD's advantage is driven primarily by stronger momentum and value, while BAC holds the stronger risk resilience profile. CHRD also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors BAC. 3 of 6 covered evidence groups favor CHRD today, and the comparison is rated Stable on stability: only 3 of 6 covered evidence groups agree. CHRD lead: Strengthening — the AIQ differential moved from 8 to 14 points over 30 sessions.
Compare Bank of America Corporation and Chord Energy Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare BAC and CHRD against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum26 vs 80CHRD +54
- Risk Resilience60 vs 50BAC +10
- Value57 vs 63CHRD +6
- Quality49 vs 50Even
3 of 6 evidence groups favor CHRD. CHRD’s edge is concentrated in momentum and value; BAC keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-10-28, compared against the prior scored session 2026-10-27.
Largest factor move: Risk Resilience +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 3 active signals are unchanged.
Largest factor move: Momentum -2
No signal started or stopped since the prior session; its 4 active signals are unchanged.
CHRD's lead narrowed by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — BAC and CHRD both carry a full feed there.
The central trade-off
CHRD (Chord Energy Corporation): the stronger current systematic profile, led by momentum and value.
BAC (Bank of America Corporation): the counter-case, on risk resilience, analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
CHRDCHRD on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
CHRDCHRD on combined revenue and EPS growth.
Value
CHRDCHRD on the peer-relative Value factor, by 6 points.
Momentum
CHRDCHRD on the Momentum factor, by 54 points.
Lower downside
BACBAC on Risk Resilience, by 10 points.
Analyst upside
BACBAC on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors CHRD, analyst targets favor BAC. That disagreement is the most useful thing on this page.
| Measure | BAC | CHRD | Note |
|---|---|---|---|
| Implied upside to target | +32.5% | +11% | BAC has more room |
| Target dispersion | +22.6% | +29.8% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 11 | 8 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor CHRD. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | CHRD | 47 vs 61 |
| Fundamentals | Even | revenue growth -3.3% vs 30.4%; EPS growth -23.8% vs 3.9%; TTM ROE 10.7% vs 10.4%; gross margin 60.4% vs 27.4%; operating margin 22.4% vs 18.9% |
| Valuation | CHRD | Value 57 vs 63 |
| Technicals | CHRD | Price vs 50-day -12.1% vs 7.8%; vs 200-day -7.5% vs 17.9% |
| Risk Resilience | BAC | Risk Resilience 60 vs 50 |
| Analyst expectations | BAC | Target upside 32.5% vs 11% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BAC and CHRD and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 14 points. (supports the conclusion holding)
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been widening. (supports the conclusion holding)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on CHRD.
How the comparison changed
120 daily snapshots · Jun 29 – Oct 28CHRD lead: Strengthening — the AIQ differential moved from 8 to 14 points over 30 sessions.
- Today
- CHRD +14
- 47 vs 61
- 7 sessions ago
- CHRD +15
- 47 vs 62
- 30 sessions ago
- CHRD +8
- 41 vs 49
- 90 sessions ago
- CHRD +9
- 50 vs 59
The lead changed hands once in this window, most recently on Jul 15 when CHRD moved ahead of BAC.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 0 bearish / 1 neutral
Only BAC
- Bollinger Band Squeeze — neutral, volatility, short horizon
4 bullish / 0 bearish
Only CHRD
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 2 more signals that do not separate them: Golden Cross Active, MACD Bullish Crossover.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.21%, AIQ 0 points).
Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +2.19%, AIQ -1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1BAC closes the Momentum gap — currently 54 points behind, the largest single contributor to CHRD's edge.
- 2BAC's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend.
- 3CHRD's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | BAC | CHRD |
|---|---|---|
| Revenue growth (YoY) | -3.3% | 30.4% |
| EPS growth (YoY) | -23.8% | 3.9% |
| Gross margin | 60.4% | 27.4% |
| Operating margin | 22.4% | 18.9% |
| Return on equity (TTM) | 10.7% | 10.4% |
| Debt to equity | 1.28 | 0.18 |
Performance
CHRD leads 6 of 6 windows| Metric | BAC | CHRD |
|---|---|---|
| 1 week (5 sessions) | 0.1% | 2.1% |
| 1 month (20 sessions) | -6.6% | 14.9% |
| 3 months (63 sessions) | -17.6% | 11.4% |
| 6 months (126 sessions) | -3.8% | 5.4% |
| Year to date | -7.5% | 66.2% |
| 1 year (252 sessions) | -3.3% | 66.6% |
Technicals
CHRD has the stronger structure| Metric | BAC | CHRD |
|---|---|---|
| RSI (14) | 31.2 | 68.4 |
| ADX (14) | 49.4 | 17.2 |
| Price vs 50-day | -12.1% | 7.8% |
| Price vs 200-day | -7.5% | 17.9% |
| Volatility (1M, annualized) | 20.8% | 32.7% |
Risk
BAC is the more resilient| Metric | BAC | CHRD |
|---|---|---|
| Beta | 0.73 | -0.77 |
| Sharpe ratio | -0.25 | 1.45 |
| Sortino ratio | -0.32 | 2.22 |
| Max drawdown | -22.3% | -25.4% |
| Current drawdown | -21.5% | -2.6% |
| Annualized volatility | 21.8% | 39.5% |
| Value at risk (95%) | -2.5% | -3.8% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, BAC or CHRD?
On the Algovestiq AIQ Score, CHRD is the stronger of the two as of Oct 31, 2026, scoring 61 against BAC's 47. The edge comes from momentum and value. BAC is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is BAC or CHRD the better buy right now?
CHRD carries the stronger systematic profile as of Oct 31, 2026, and the comparison is rated Stable — 3 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor CHRD over BAC?
The composite weights Quality, Value, Momentum and Risk Resilience. CHRD leads Momentum by 54 points; BAC leads Risk Resilience by 10 points; CHRD leads Value by 6 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, BAC or CHRD?
Analyst price targets imply +32.5% upside for BAC and +11% for CHRD, so the Street currently favors BAC. That points the opposite way to the AIQ Score, which favors CHRD. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, BAC or CHRD?
CHRD is the better-valued of the two on the peer-relative Value factor. CHRD on the peer-relative Value factor, by 6 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, BAC or CHRD?
CHRD on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, BAC or CHRD?
CHRD on the Momentum factor, by 54 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, BAC or CHRD?
BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 10 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is BAC more profitable than CHRD?
BAC leads on the comparable margin measures — gross margin 60.4% vs 27.4%; operating margin 22.4% vs 18.9%; ttm roe 10.7% vs 10.4%.
Is CHRD's lead over BAC getting stronger or weaker?
CHRD lead: Strengthening — the AIQ differential moved from 8 to 14 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-29 and 2026-10-28. The lead has changed hands once in that window, most recently on 2026-07-15, when CHRD moved ahead of BAC.
What would change the BAC vs CHRD verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BAC closes the Momentum gap — currently 54 points behind, the largest single contributor to CHRD's edge; BAC's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend; CHRD's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about BAC and CHRD?
BAC: 2 bullish / 0 bearish / 1 neutral. CHRD: 4 bullish / 0 bearish. The most decision-relevant rule on BAC is Golden Cross Active (bullish, long horizon). On CHRD it is Golden Cross Active (bullish, long horizon).
Compare BAC and CHRD with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.